PCN61 MULTI-STATE SURVIVAL ANALYSIS IN COST-EFFECTIVENESS STUDIES-THE CASE OF CAPECITABINE VERSUS DOCETAXEL IN METASTATIC BREAST CANCER (MBC) FORA PRIVATE PAYER IN BRAZIL
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65219-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)65219-9/fulltext
Section Title :
Section Order :
377
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65219-9&doi=10.1016/S1098-3015(10)65219-9